Literature DB >> 24256639

The ABCs of RVO: a review of retinal venous occlusion.

Derek MacDonald1.   

Abstract

Retinal vein occlusions are important causes of loss of vision; indeed, they are the second most common retinal vascular disease, following diabetic retinopathy. For this reason alone, primary eye-care providers must be well versed in diagnosis and management. Risk factors, though not universally agreed upon, include but are not limited to advancing age, systemic hypertension, arteriolarsclerosis, diabetes, hyperlipidaemia, blood hyperviscosity, thrombophilia, ocular hypertension and glaucoma. Typically, visual loss is secondary to macular oedema and/or retinal ischaemia. Treatment modalities have included observation, systemic thrombolysis and haemodilution, radial optic neurotomy, chorioretinal anastomosis, vitrectomy, laser photocoagulation and intravitreal injection of anti-inflammatory and, most recently, anti-vascular endothelial growth factors.
© 2013 The Author. Clinical and Experimental Optometry © 2013 Optometrists Association Australia.

Entities:  

Keywords:  aflibercept; bevacizumab; macular oedema; pegaptanib; ranibizumab; retinal vein occlusion; sheathotomy; vascular endothelial growth factor; vitrectomy

Mesh:

Year:  2013        PMID: 24256639     DOI: 10.1111/cxo.12120

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  15 in total

1.  FELLOW EYE CHANGES IN PATIENTS WITH NONISCHEMIC CENTRAL RETINAL VEIN OCCLUSION: Assessment of Perfused Foveal Microvascular Density and Identification of Nonperfused Capillaries.

Authors:  Alexander Pinhas; Michael Dubow; Nishit Shah; Eric Cheang; Chun L Liu; Moataz Razeen; Alexander Gan; Rishard Weitz; Yusufu N Sulai; Toco Y Chui; Alfredo Dubra; Richard B Rosen
Journal:  Retina       Date:  2015-10       Impact factor: 4.256

2.  Central retinal vein occlusion caused by hyperviscosity syndrome in a young patient with Sjögren's syndrome and MALT lymphoma.

Authors:  Atsushi Yoshida; Meri Watanabe; Ken Ohmine; Hidetoshi Kawashima
Journal:  Int Ophthalmol       Date:  2015-02-25       Impact factor: 2.031

3.  Radial optic neurotomy in treating central retinal vein occlusion: a Meta-analysis.

Authors:  Zhen-Na Chen; Yan Shao; Xiao-Rong Li
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

4.  Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability.

Authors:  Crystal Colón Ortiz; Anna Potenski; Jaqueline M Lawson; Jade Smart; Carol M Troy
Journal:  J Vis Exp       Date:  2021-08-06       Impact factor: 1.424

Review 5.  Thrombosis and Hemorrhage in Diabetic Retinopathy: A Perspective from an Inflammatory Standpoint.

Authors:  Nivetha Murugesan; Tuna Üstunkaya; Edward P Feener
Journal:  Semin Thromb Hemost       Date:  2015-08-25       Impact factor: 4.180

Review 6.  An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients.

Authors:  Gustavo Schvartsman; Michael J Wagner; Chrystia M Zobniw; Van Anh Trinh; Shreyaskumar Patel; Neeta Somaiah
Journal:  Curr Oncol Rep       Date:  2016-08       Impact factor: 5.075

7.  [Retinal vein occlusion and hyper-viscosity syndrome].

Authors:  Samar Younes; Meriem Abdellaoui; Fadoua Zahir; Idriss A Benatiya; Hicham Tahri
Journal:  Pan Afr Med J       Date:  2015-01-05

Review 8.  Ranibizumab for the treatment of degenerative ocular conditions.

Authors:  Magdalini Triantafylla; Horace F Massa; Doukas Dardabounis; Zisis Gatzioufas; Vassilios Kozobolis; Konstantinos Ioannakis; Irfan Perente; Georgios D Panos
Journal:  Clin Ophthalmol       Date:  2014-06-24

9.  Gene expression profiling in a mouse model of retinal vein occlusion induced by laser treatment reveals a predominant inflammatory and tissue damage response.

Authors:  Gottfried Martin; David Conrad; Bertan Cakir; Günther Schlunck; Hansjürgen T Agostini
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

Review 10.  Optical Coherence Tomography Angiography in Retinal Diseases.

Authors:  K V Chalam; Kumar Sambhav
Journal:  J Ophthalmic Vis Res       Date:  2016 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.